Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Shetland ponies help allergy sufferers
Shetland
“To our knowledge, this is the very first study of a natural allergic disease in which we can show that immune responses to allergens can take two directions."

Horse immune system acts in two different ways in response to midge bites

Shetland ponies are helping researchers understand how people could be prevented from developing allergies, according to a new study.

Researchers at the University of Edinburgh said that the horse immune system responds to midge bites in a way that prevents, rather than triggers, allergic reactions.

The study of Shetland ponies found that their immune system acts in two different ways in response to midge bites.

One of these responses triggers allergy symptoms, such as itching and inflammation, while the other prevents an allergic reaction.

The team found that after being exposed to midges, the horse immune system releases various types of factors, known as cytokines, which affect the behaviour of other cells.

Ponies that react to midge bites release cytokines, known as IL-4, which trigger allergy symptoms.

In ponies not sensitive to bites, another cytokine, INF-g, is released, blocking different immune cells that would otherwise trigger allergic reactions.

The researchers say that by priming the human immune system to respond to allergens in a way that does not trigger reactions, it could be possible to prevent people developing allergies.

Lead author of the study, Dr Dietmar Zais from the University of Edinburgh's School of Biological Sciences, said:  “To our knowledge, this is the very first study of a natural allergic disease in which we can show that immune responses to allergens can take two directions, either leading to allergy or to tolerance.

"We believe this finding could have direct practical implications, for example by helping immune responses to choose the 'right' direction in individuals who we would like to protect from developing occupation-associated allergies.”

The study, published in the journal PLOS ONE, was funded by the Dutch Foundation for Technical Sciences (STW) and was carried out in collaboration with researchers in the Netherlands.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.